4. Proof of “Vaccine” Death

Case Study – Proof of Vaccine Death – Not Caused by SARS.

 

A 76-year-old man with Parkinson’s disease died three weeks after third COVID-19 vaccination. (May 2021, ChAdOx1 vaccine, July 2021, Pfizer vaccine, December 2021, Pfizer vaccine).

Research paper:

https://www.mdpi.com/2076-393X/10/10/1651

Russian COVID-19 Coronavirus Vaccine and Syringe Concept Image.

The family of the deceased requested an autopsy, due to ambiguous clinical signs before death. PD was confirmed by post-mortem examinations. Signs of aspiration pneumonia and systemic arteriosclerosis.

 

 

Histopathological analyses of the brain and other organs showed:

  • acute vasculitis (predominantly lymphocytic),
  • multifocal necrotizing encephalitis,
  • pronounced inflammation
  • Glial and lymphocytic reaction
  • In the heart signs of chronic cardiomyopathy
  • Mild acute lympho-histiocytic myocarditis and vasculitis

Patient had no history of COVID-19. Immunohistochemistry for SARS-CoV-2 antigens (spike and nucleocapsid proteins) was performed.

 

 

Only spike protein but no nucleocapsid protein could be detected, within the foci of inflammation, brain and heart. Spike protein detected in the endothelial cells of small blood vessels.

 

 

Since no nucleocapsid protein could be detected, the presence of spike protein must be ascribed to vaccination rather than to viral infection.

 

 

The findings corroborate previous reports of encephalitis and myocarditis caused by gene-based COVID-19 vaccines. A causal connection of these findings to the preceding COVID-19 vaccination was established by immunohistochemical demonstration of SARS-CoV-2 spike protein.

 

 

The methodology introduced in this study should be useful for distinguishing between causation by COVID-19 vaccination or infection in ambiguous cases. Clinicians should take note of such case reports for the sake of early detection and management of such adverse events among their patients.

 

 

A thorough post-mortem examination of deaths in connection with COVID-19 vaccination should be considered in ambiguous circumstances, including histology.

 

 

Clinical History:

First vaccination in May 2021 (ChAdOx1) He experienced pronounced cardiovascular side effects. After the second vaccination in July 2021 (BNT162b2) Family noted obvious behavioral and psychological changes (e.g., he did not want to be touched, anxiety, lethargy, social withdrawal). Striking worsening of his PD symptoms 2 weeks after the third vaccination. Suddenly collapsed. Collapsed again 2 weeks after, died shortly thereafter. Clinical diagnosis was death due to aspiration pneumonia.

 

Video explaining this case study:

https://youtu.be/NZhzWzoPB3M

 
Dr. Thomas Lewis

Dr. Thomas Lewis

Dr. Thomas J. Lewis holds a Ph.D. from MIT and certifications in toxicology and nutrition from the Harvard School of Public Health. He obtained the majority of his training in health from Harvard Medical School professors Kilmer S. McCully, M.D., and Clement L. Trempe., M.D.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
X